(VRTX) said that Health Canada has granted Marketing Authorization for CASGEVY (exagamglogene autotemcel), an autologous genome edited hematopoietic stem cell-based therapy, for the treatment of ...
Keywords: Bone, hematopoiesis, malignancy, osteohematopoietic niche, osteoblasts, osteoclasts, metabolism, hormones. Important Note: All contributions to this Research Topic must be within the scope ...
Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...